Cargando…

Carfilzomib-induced pulmonary hypertension with associated right ventricular dysfunction: A case report

Carfilzomib, a selective proteasome inhibitor, is approved for use in relapsed and refractory multiple myeloma. Its link to left ventricular dysfunction is well established but little is known about its effects on the right ventricle. One of its rare complications is pulmonary hypertension, which at...

Descripción completa

Detalles Bibliográficos
Autores principales: McGregor, Pei-Chun, Boosalis, Valia, Aragam, Jayashri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890743/
https://www.ncbi.nlm.nih.gov/pubmed/33643656
http://dx.doi.org/10.1177/2050313X21994031

Ejemplares similares